JZP150
Showing 1 - 8 of 8
Excessive Daytime Sleepiness Associated With Obstructive Sleep Apnea Trial in China (Solriamfetol, Placebo)
Recruiting
- Excessive Daytime Sleepiness Associated With Obstructive Sleep Apnea
- Solriamfetol
- Placebo
-
ShangHai, Shanghai, China
- +25 more
Oct 26, 2023
Excessive Daytime Somnolence, Obstructive Sleep Apnea Trial in Worldwide (Solriamfetol, Placebo)
Active, not recruiting
- Excessive Daytime Somnolence
- Obstructive Sleep Apnea
- Solriamfetol
- Placebo
-
Los Angeles, California
- +27 more
May 31, 2022
Obstructive Sleep Apnea, Excessive Sleepiness Trial in Maastricht (JZP-110, Placebo)
Completed
- Obstructive Sleep Apnea
- Excessive Sleepiness
- JZP-110
- Placebo
-
Maastricht, Limburg, NetherlandsMaastricht University
Dec 21, 2020
Narcolepsy, Excessive Sleepiness Trial in Maastricht (JZP-110, Placebo)
Completed
- Narcolepsy
- Excessive Sleepiness
- JZP-110
- Placebo
-
Maastricht, Limburg, NetherlandsMaastricht University
Dec 21, 2020
Excessive Sleepiness, Parkinson Disease Trial in United States (JZP-110, Placebo)
Completed
- Excessive Sleepiness
- Parkinson Disease
- JZP-110
- Placebo
-
Los Angeles, California
- +24 more
Jan 3, 2020
Narcolepsy Trial in Worldwide (JZP-110, Placebo oral tablet)
Obstructive Sleep Apnea Trial in Worldwide (JZP-110, Placebo oral tablet)
Completed
- Obstructive Sleep Apnea
- JZP-110
- Placebo oral tablet
-
Glendale, Arizona
- +58 more
Jul 21, 2019